Protein & Cell >

2022 , Vol. 13 >Issue 9: 694 - 700

DOI: https://doi.org/10.1007/s13238-021-00833-y

CORRECTION

Correction to: Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling

  • Juanjuan Yuan 1,2,4 ,
  • Ting Cai 1,2,4 ,
  • Xiaojun Zheng 2,3,4 ,
  • Yangzi Ren 2,3 ,
  • Jingwen Qi 2,4 ,
  • Xiaofei Lu 2,4 ,
  • Huihui Chen 2,4 ,
  • Huizhen Lin 2,4 ,
  • Zijie Chen 2,4 ,
  • Mengnan Liu 2,4 ,
  • Shangwen He 2,4 ,
  • Qijun Chen 2,4 ,
  • Siyang Feng 2,4 ,
  • Yingjun Wu 2,4 ,
  • Zhenhai Zhang , 5 ,
  • Yanqing Ding , 2,3,4 ,
  • Wei Yang , 2,3,4
Expand
  • 1. Shunde Hospital, Southern Medical University (The First People’s Hospital of Shunde), Foshan 528308, China
  • 2. Guangdong Provincial Key Laboratory of Molecular Oncologic Pathology, Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China
  • 3. Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
  • 4. Guangdong Provincial Key Laboratory of Molecular Oncologic Pathology, Southern Medical University, Guangzhou 510515, China
  • 5. Center for Precision Medicine, Guangdong Provincial People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510030, China

Published date: 15 Sep 2022

Copyright

2022 The Author(s)
Fold

Cite this article

Juanjuan Yuan , Ting Cai , Xiaojun Zheng , Yangzi Ren , Jingwen Qi , Xiaofei Lu , Huihui Chen , Huizhen Lin , Zijie Chen , Mengnan Liu , Shangwen He , Qijun Chen , Siyang Feng , Yingjun Wu , Zhenhai Zhang , Yanqing Ding , Wei Yang . Correction to: Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling[J]. Protein & Cell, 2022 , 13(9) : 694 -700 . DOI: 10.1007/s13238-021-00833-y

Options
Outlines

/

〈 〉